Name

Aclidinium

Description

Aclidinium is an anticholinergic for the long-term management of chronic obstructive pulmonary disease (COPD). It has a much higher propensity to bind to muscarinic receptors than nicotinic receptors. FDA approved on July 24, 2012.

Brands

Company not known

Bretaris Genuair

Company not known

Eklira Genuair